Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Breast Cancer (Tokyo, Japan)|June 24, 2026
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trialTakashi Yamanaka, Joohyuk Sohn, Kazuki Sudo, et al.
Translational Oncology|July 24, 2024
TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohortsShin Takahashi, Nobuaki Sato, Kouji Kaneko, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
The New England Journal of Medicine|December 11, 2024
Imlunestrant with or without Abemaciclib in Advanced Breast CancerKomal L Jhaveri, Patrick Neven, Monica Lis Casalnuovo, et al.
NPJ Breast Cancer|August 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancerEmi Noguchi, Takashi Yamanaka, Hirofumi Mukai, et al.
The New England Journal of Medicine|June 6, 2022
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, William Jacot, Toshinari Yamashita, et al.
Pageof 16